NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
18 hedge funds and large institutions have $720K invested in InVivo Therapeutics Holdings Corp in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$522K | |
| 2 | +$7.92K | |
| 3 | +$73 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$10 |
| 5 |
CTA
Colonial Trust Advisors
Spartanburg,
South Carolina
|
+$5 |
Top Sellers
| 1 | -$184K | |
| 2 | -$49K | |
| 3 | -$45K | |
| 4 |
Renaissance Technologies
New York
|
-$41.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.99K |